A Comparative Concepto Clinical Analysis on Ardite navanam murdhni tailam tarpanameva cha W.R.T.Karpasasthyadi taila
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- symptoms of ardita relieved
研究概览
简要总结
Chikista sutra of Ardita is focusing on tarpana in the form of navana and murdhni taila Nasya in Ardita is accepted by almost all Acharyaswhere as Shirobasti is the line of treatment according to SushrutaCharaka and Vagbhata mentions murdhini tailaAnd Vagbhata says amongst 4 murdhni tailas Shirobasti is the best
According to Tailaprakarana of Sahasrayoga the phalashruti of Karpasasthyadi taila is pakshagataardita harethwhere the ingredients like Karpasasthi Bala Masha having guru snigdha guna madhura vipaka sheeta virya are vatakapha hara and balyain nature and ingredients like Rasna Nagara Kusta having tikta katu rasa katu vipaka usna veerya are kapha shamaka in nature As per chikista sutra navana and murdhni taila procedures are to be adopted in the management of Arditaso here is A COMPARATIVE CONCEPTO CLINICAL ANALYSIS ON ARDITE NAVANAM MURDHNI TAILAM TARPA NAMEVA CHAAn attempt to evaluate and compare the efficacy of single drug Karpasasthyadi taila for both procedures will be made
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Subjects presenting with classical symptoms of Ardita Subjects from either sex will be selected in the age group of 20-60 years Subjects fit for Nasya Karma and Shirobasti.
排除标准
- •Subjects with more than 3 years of history of Ardita Ardita associated with Pakshagata bilateral facial nerve paralysis intracranial hemorrhageneoplasm multiple sclerosis Subjects with other systemic disorders which interfere with course of treatment and autoimmune disorders Subjects with uncontrolled diabetic mellitus Pregnant women.
结局指标
主要结局
symptoms of ardita relieved
时间窗: 7 days
次要结局
未报告次要终点
研究者
Dr Shobha
Ayurveda Mahavidyalaya and Hospital heggeri extension old hubballi